Holocene Advisors, LP Jazz Pharmaceuticals PLC Transaction History

Holocene Advisors, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $694,146 - $807,757	-4,333 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $100 Million - $116 Million	-667,236 Reduced 99.35%	4,333 $712,000
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $21.4 Million - $25.1 Million	-151,833 Reduced 18.44%	671,569 $111 Million
Q3 2020 Nov 16, 2020	BUY	$105.46 - $144.13 $35.9 Million - $49.1 Million	340,749 Added 70.6%	823,402 $117 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $1.47 Million - $1.88 Million	15,404 Added 3.3%	482,653 $53.3 Million
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $26.2 Million - $45.6 Million	298,775 Added 177.34%	467,249 $46.6 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $19.8 Million - $25.9 Million	168,474 New	168,474 $25.2 Million
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $241,298 - $302,063	-1,649 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $416,532 - $482,795	-3,072 Reduced 65.07%	1,649 $249,000
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $618,734 - $709,991	4,721	4,721 $636,000

490

57M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.99B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.